1.The role of GIS in deliveringEffective Humanitarian AssistanceGeorge Mu’ammar VAM - Food Security Analysis Service United Nations World Food Programme, Rome, ITALY [email protected]…

Slide 1 Dr. Gopichand Pendurti M.B.B.S ACTIVITY OF RITUXIMAB AND OFATUMUMAB AGAINST MANTLE CELL LYMPHOMA(MCL) IN VITRO IN MCL CELL LINES BY COMPLEMENT DEPENDENT CYTOTOXICITY…

Slide 1 Multiple Myeloma: ASH 2005 Steven Coutre, M.D. Associate Professor of Medicine Division of Hematology Stanford University School of Medicine Slide 2 Quality of Remission…

Slide 1 Steele Taylor presents: A Neuro-Endocrine Approach to The Obstetric and Pediatric Applications of Tactile-Kinesthetic Stimulation Therapy questions/complaints: [email protected]…

Slide 1 Differential Reinforcement & Differential Punishment Chapter 7 Slide 2 Selecting Behaviors Already in repertoire of behavior Selecting and strengthening particular…

Slide 1 Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy…

Slide 1 STN 125011 Tositumomab Therapeutic Regimen (TTR) [tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002 Slide 2 Proposed Indication…

Slide 1 Update: Non-Hodgkin’s Lymphoma 20082008 Slide 2 ICML 2008: Update on non-Hodgkin’s lymphoma Diffuse Large B-cell Lymphoma  Improved outcome of elderly patients…

New Evidence reports on presentations given at ASH 2010 Rituximab in the Treatment of NHL: Rituximab versus Watch and Wait in Asymptomatic FL, R-Maintenance Therapy in FL…

Slide 1 Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer Presented By Junzo Hamanishi at 2014…